All In Biotech

Free tool

FAERS Monitor: Enzeevu

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761382 or its brand name (Enzeevu, Aflibercept-Abzv). Reports on generic versions are filed under their own applications.

Reports

3,454

Serious

3,281

95% of reports

Hospitalization

1,431

Death reported

418

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use450
  • diarrhoea377
  • neutropenia215
  • hypertension204
  • asthenia152
  • disease progression147
  • visual acuity reduced141
  • drug ineffective122
  • fatigue118
  • endophthalmitis116
  • nausea116
  • thrombocytopenia106
  • general physical health deterioration100
  • abdominal pain99
  • anaemia99

Reports by year received

View as table
YearReports
20075
20082
200911
201045
201127
201257
2013240
2014162
2015159
2016180
2017182
2018532
2019328
2020212
2021200
2022170
2023198
2024203
2025238
2026303

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,705 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
endophthalmitisSignal116120.0100.213,317
visual acuity reducedSignal14126.022.13,350
neutropeniaSignal2159.68.51,665
disease progressionSignal1477.66.5836
hypertensionSignal2045.95.1827
thrombocytopeniaSignal1065.84.8416
general physical health deteriorationSignal1005.34.3343
diarrhoeaSignal3773.63.2712
anaemiaSignal993.22.6145
off label useSignal4503.12.9678
abdominal painSignal992.62.196
astheniaSignal1522.52.1133
fatigue1180.90.81
nausea1160.90.71
drug ineffective1220.60.543

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.